Connect with us

Stock Market Breaking News

ParcelPal (PTNYF) (PKG) Announces Strategic Partnership With MADD Canada to Stop Impaired Driving

Joe Samuel

Published

on

VANCOUVER , Jan. 29, 2019 /CNW/ – ParcelPal Technology Inc. (“ParcelPal” or the “Company”), (PKG.CN) (PT0.F) (PTNYF) is pleased to announce that it has formed a partnership with MADD Canada to aid in the continuous fight to prevent impaired driving. MADD Canada has endorsed ParcelPal as their official delivery service in Canada .

Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market

MADD Canada has over 100 Chapters and Community Leaders in Canada and provides education and awareness programs to educate the public on the dangers of driving while under the influence of alcohol, cannabis and/or other drugs. As part of the ParcelPal’s national rollout campaign, advertising for ParcelPal’s service will be seen across the country in various educational forms. Together, MADD Canada and ParcelPal will launch a national awareness campaign focused on educating Canadians on the dangers of impaired driving and the options they have for getting items they want or need without leaving the party. This awareness campaign, which will be launched through social media and live television, will appeal to party-goers to not leave for cannabis, alcohol or other items if they don’t have to – “Don’t drive impaired; ParcelPal it”.

President and CEO Kelly Abbott States , “As ParcelPal dives deeper into cannabis and alcohol delivery, we are very aware of the inherent risks associated with consumption. We take every precaution to ensure the product is not only delivered safely but will be consumed responsibly as well. Our driver training programs and our technology are designed to ensure they do not deliver to a highly intoxicated or underage person.” Abbott continues, “Most of our orders are later weekend nights, where people are already at a party or are at home with friends. With ParcelPal, why leave? We take the risk away from people leaving the party to ‘re-up’ on their booze, cannabis, or snacks among many other use-cases. If this awareness campaign can change the lives of just one family – it is totally worth it.”

Customers who order cannabis or alcohol through the ParcelPal platform will be required to upload and verify their identities. Users that are under the age within their jurisdictions will not be allowed into this vertical on the application. The identity verification system ensures that the person is of age and that the identity is in fact real, and it is checked twice – once before and once upon delivery. Consumers who order product will have to be the person to receive the order. ParcelPal’s technology complies with all local, provincial and federal laws.

About ParcelPal Technology Inc.

ParcelPal is a technology-driven logistics company that connects consumers to the goods they love. Customers can shop at partner businesses and through the ParcelPal technology receive their purchased goods within an hour. The Company offers on-demand delivery of merchandise from leading retailers, restaurants, medical marijuana dispensaries and liquor stores in Vancouver and soon in major cities Canada -wide.

ParcelPal Website: http://www.parcelpal.com

The Canadian Securities Exchange (“CSE”) or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release that has been prepared by management.

CSE – Symbol: PKG

FSE – Symbol: PT0

OTC – Symbol: PTNYF

Forward Looking Information

This news release contains forward looking statements relating to the Proposed Transaction, and the future potential of ParcelPal. Forward looking statements are often identified by terms such as “will”, “may”, “should”, “intends”, “anticipates”, “expects”, “plans” and similar expressions. All statements other than statements of historical fact, included in this release are forward looking statements that involve risks and uncertainties. These risks and uncertainties include, without limitation, the risk that the Proposed Transaction will not be completed due to, among other things, failure to execute definitive documentation, failure to complete satisfactory due diligence, failure to receive the approval of the CSE and the risk that ParcelPal will not be successful due to, among other things, general risks relating to the mobile application industry, failure of ParcelPal to gain market acceptance and potential challenges to the intellectual property utilized in ParcelPal. There can be no assurance that any forward looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

The Company cannot guarantee that any forward looking statement will materialize and the reader is cautioned not to place undue reliance on any forward looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward looking statements contained in this news release are expressly qualified by this cautionary statement. The forward looking statements contained in this news release are made as of the date of this news release and the Company will only update or revise publicly any of the included forward looking statements as expressly required by Canadian securities laws.

SOURCE ParcelPal Technology Inc.

Continue Reading
Click to comment

Featured

ParcelPal (PKG.CN) (PTNYF) Achieves Milestone of Delivering Over 2,500,000 Packages

Joe Samuel

Published

on

delivery stocks to buy

VANCOUVER, British Columbia, June 21, 2019 (GLOBE NEWSWIRE) — ParcelPal Technology Inc. (“ParcelPal” or the “Company”), (CSE:PKG) (PT0.F) (PTNYF) is pleased to announce they have achieved a major milestone of delivering over 2,500,000 packages to date. Furthermore, the Company has also had early success in Saskatchewan across all verticals including Cannabis. The company plans to engage in further partnerships, enter new cities and will report on progress in the near future. As time and regulations allow, ParcelPal’s cannabis network will continue to grow, with the goal of capturing a major piece of North America’s expected $60.0B legal cannabis market.

[Special Report] On-Demand Tech Takeover: Here’s What You Should Know

This milestone provides further validation that ParcelPal’s innovative technology is revolutionizing the on-demand delivery space as consumers and merchants are turning to the company to make this process both simple and efficient. ParcelPal has shifted the paradigm from a simple on-demand delivery company to being a full comprehensive eCommerce platform that allows consumers in to purchase anything legal and have those goods delivered in under an hour. ParcelPal’s go-forward plan includes pushing the ParcelPal platform on multiple consumer verticals in addition to further expanding their reach across Canada and the US.

We are continuously engaging in business development within Canada and the US to find other growth catalysts, whilst expanding existing partnerships in all verticals, including Cannabis and Liquor as these would result in higher margins and are significantly underserviced segments. The Company is still focusing their efforts on user acquisition, small business and large eCommerce contracts and various verticals for delivery. Since the launch of operations in late July 2017, the Company has grown revenue over 802% from 2017 to 2018. The Company expects this growth to continue as we expand our footprint across Canada and the US.

President and CEO, Kelly Abbott states, “We are extremely excited to have achieved this major milestone of 2,500,000. Our growth over the past year has been tremendous and we’re looking forward to taking advantage of the many opportunities that have presented themselves for the remaining part of the year specifically in the liquor and Cannabis space with near-term plans to enter Ontario. I would especially like to thank my team for all of the hard work and dedication to continue achieving milestones.”

About ParcelPal Technology Inc.

ParcelPal is a technology-driven logistics company that connects consumers to the goods they love. Customers can shop at partner businesses and through the ParcelPal technology receive their purchased goods within an hour.  The Company offers on-demand delivery of merchandise from leading retailers, restaurants, medical marijuana dispensaries and liquor stores in Vancouver and soon in major cities Canada-wide.

ParcelPal Website: www.parcelpal.com

The Canadian Securities Exchange (“CSE”) or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release that has been prepared by management.

CSE – Symbol: PKG
FSE – Symbol: PT0
OTC – Symbol: PTNYF

Contact: Peter Hinam, Investor Relations – peter@parcelpal.com 

Forward Looking Information

We seek safe harbour

This news release contains forward looking statements relating to the Proposed Transaction, and the future potential of ParcelPal.  Forward looking statements are often identified by terms such as “will”, “may”, “should”, “intends”, “anticipates”, “expects”, “plans” and similar expressions.  All statements other than statements of historical fact, included in this release are forward looking statements that involve risks and uncertainties.  These risks and uncertainties include, without limitation, the risk that the Proposed Transaction will not be completed due to, among other things, failure to execute definitive documentation, failure to complete satisfactory due diligence, failure to receive the approval of the CSE and the risk that ParcelPal will not be successful due to, among other things, general risks relating to the mobile application industry, failure of ParcelPal to gain market acceptance and potential challenges to the intellectual property utilized in ParcelPal.  There can be no assurance that any forward looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. 

The Company cannot guarantee that any forward looking statement will materialize and the reader is cautioned not to place undue reliance on any forward looking information.  Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.  Forward looking statements contained in this news release are expressly qualified by this cautionary statement.  The forward looking statements contained in this news release are made as of the date of this news release and the Company will only update or revise publicly any of the included forward looking statements as expressly required by Canadian securities laws.

Continue Reading

Biotechnology

GT Biopharma (GTBP) Update: Market Momentum Pushing Biotech Stocks To New Levels

Joe Samuel

Published

on

Sure, the S&P is reaching new highs, tech is red hot, and oil is surging…but guess what: One industry that the market essentially wrote off in the second quarter just made NEW 3rd Quarter Highs and that could mean big things for biotech stocks.

biotech stocks IBB etf

There’s no denying that the vast majority of multi-billion dollar mergers and acquisitions have been in the biotech sector. Mainly it has been companies that offer novel immune therapies that have caught the attention. This is a big reason why the sector could become an even bigger focus for the second half of 2019.

Our Focus On GT Biopharma

GT Biopharma Inc. (GTBP) has been a key focus on StockPrice.com for a few weeks now and for the most part, it has moved in tandem with the broader biotech sector. A Key Driver has been BIG M&A. Large and Mega Cap companies are scooping up smaller biotech firms that focus on cancer-fighting treatments and have immunotherapy pipelines. And guess what category GT Biopharma Inc. (GTBP) falls into…

GT Biopharma Inc. (GTBP) is a small-cap biotech company that creates immune-oncology products. They utilize a technology platform that combines antibody-drug linkers to single-chain, bi-, tri-, and tetra-specific scFv constructs to produce treatments. One example is for carcinoma, called OXS-1615, which is a tetraspecific treatment.

Since we initiated coverage on the company, we’ve watched GTBP climb as much as 30% and as of June 20, it’s still up by roughly 15.5% in just over a week. We have seen a bit of consolidation to start this week but as we said earlier this month, that could open the door to more excitement in June. The big focus for those looking at GTBP has been on its immunotherapy portfolio.

The Next Step For Immunotherapies
GT Biopharma Pipeline Commands Attention

To date, GT Biopharma has completed one dose escalation Phase I-II expansion clinical trial, and one fixed dose Phase I-II expansion clinical trial, which collectively enrolled a combined 43 patients. On the surface, the Phase I-II expansion clinical trial demonstrated greater than 50% of Evaluable patients receiving 60 mg/kg dose had a positive clinical response.

Two patients exhibited a Complete Remission with one patient currently disease-free at 50 months post-treatment. Additionally, five patients exhibited Stable Disease, cancers that are neither increasing nor decreasing in severity, with the longest response lasting 12 months post-treatment.

The global market for cancer drugs is estimated to be about $123 billion and big players are investing heavily to gain an edge in this increasingly competitive market[1].  

“GTB-1550 has shown positive results in its two Phase I-II clinical trials in advanced cancer patients who have failed all other therapies, and we are now planning to proceed with a Phase II clinical trial.”

Anthony Cataldo, the Chairman and Chief Executive Officer of GT Biopharma

In addition to this, the company’s therapy has also shown that it could target HIV infected cells in the University of Minnesota’s preclinical testing. Not only that but in specific tests, data showed that HIV-infected targets that express the HIV envelope on their surface could be eliminated.

What’s Next For GT Biopharma (GTBP)?

In our opinion, market timing for biotech has been a major focus for many. Cancer research remains one of the most critical areas of focus for most investors. This is simply due to the fact that if a company can come up with a truly path-breaking product, then the potential for growth could be significant.

The recent deal between Merck and Tilos Therapeutics has sparked increased enthusiasm within the industry. This just adds yet another big deal to the rapidly growing list of big biotech buyouts in the immunotherapy and cancer research arena. The health sciences market is experiencing unprecedented innovation, and now the race is to get behind the next breakthrough. GT Biopharma’s numerous phase trials, novel treatments, and top tier leadership could be key factors to pay close attention to, considering the current climate for biopharma stocks.

[Read More] We’ve put together a full report on GTBP so click here for more info.

biotech stocks to buy now
Pursuant to an agreement between MIDAM VENTURES, LLC and GT Biopharma, Midam was hired for a period from 06/07/2019 – 7/07/2019 to publicly disseminate information about GT Biopharma including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for & were paid “0” shares of restricted common shares. We may buy or sell additional shares of GT Biopharma in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer.

Endnotes:

[1]Brad Loncar -https:// finance. yahoo. com /news/why-cancer-fighting-stocks-etfs-184606099. html

Continue Reading

Featured

Stock Price Thursday Morning Market Update – June 20, 2019

A. Lawrence

Published

on

Biotech Companies Are Driving Innovation. See Which Ones Could Be Leading The Charge, Now!

Click Here To Read More


4 Security Penny Stocks To Watch

See For Yourself


Two Massive Growth Industries, One Choice for Investors

The Fastest Growing Industries Yet? CLICK HERE


Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


We keep all user information pricate & promise to never spam.*

Privacy Policy

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com